Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma | Journal of Neurology, Neurosururgery & Psychiatry
Dopamine agonist withdrawal syndrome (DAWS) is a recently described syndrome where patients withdrawn from long-term treatment with dopamine agonists experience a constellation of neuropsychiatric and autonomic symptoms. Foi inicialmente descrita…